Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
4R37AI029912-11
Application #
6401867
Study Section
Special Emphasis Panel (NSS)
Program Officer
Johnson, David R
Project Start
1992-02-01
Project End
2003-01-31
Budget Start
2002-02-15
Budget End
2003-01-31
Support Year
11
Fiscal Year
2002
Total Cost
$324,750
Indirect Cost

  Institution

Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143

  Publications

Yadav, Mahesh; Goetzl, Edward J (2008) Vasoactive intestinal peptide-mediated Th17 differentiation: an expanding spectrum of vasoactive intestinal peptide effects in immunity and autoimmunity. Ann N Y Acad Sci 1144:83-9
Goetzl, Edward J; Chan, Robert C; Yadav, Mahesh (2008) Diverse mechanisms and consequences of immunoadoption of neuromediator systems. Ann N Y Acad Sci 1144:56-60
Voice, Julia; Donnelly, Samantha; Dorsam, Glenn et al. (2004) c-Maf and JunB mediation of Th2 differentiation induced by the type 2 G protein-coupled receptor (VPAC2) for vasoactive intestinal peptide. J Immunol 172:7289-96
Grinninger, Carola; Wang, Wengang; Oskoui, Kaveh Bastani et al. (2004) A natural variant type II G protein-coupled receptor for vasoactive intestinal peptide with altered function. J Biol Chem 279:40259-62
Voice, Julia K; Grinninger, Carola; Kong, Yvonne et al. (2003) Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type II VIP receptor transgenic mice. J Immunol 170:308-14
Voice, Julia K; Dorsam, Glenn; Chan, Robert C et al. (2002) Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide. Regul Pept 109:199-208
Dorsam, Glenn; Goetzl, Edward J (2002) Vasoactive intestinal peptide receptor-1 (VPAC-1) is a novel gene target of the hemolymphopoietic transcription factor Ikaros. J Biol Chem 277:13488-93
Voice, J K; Dorsam, G; Lee, H et al. (2001) Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor. FASEB J 15:2489-96
Goetzl, E J; Voice, J K; Shen, S et al. (2001) Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide. Proc Natl Acad Sci U S A 98:13854-9
Dorsam, G; Voice, J; Kong, Y et al. (2000) Vasoactive intestinal peptide mediation of development and functions of T lymphocytes. Ann N Y Acad Sci 921:79-91

Showing the most recent 10 out of 33 publications